Published in Arch Ophthalmol on March 01, 1977
Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Br Med J (1978) 2.96
Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol (2000) 2.06
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis (1994) 2.03
The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci (2011) 1.80
The questionably dry eye. Br J Ophthalmol (1981) 1.46
The challenge of dry eye diagnosis. Clin Ophthalmol (2008) 1.28
Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol (2014) 0.92
Concordance between common dry eye diagnostic tests. Br J Ophthalmol (2008) 0.87
Tear film images and breakup analyzed using fluorescent quenching. Invest Ophthalmol Vis Sci (2013) 0.83
Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis. Medicine (Baltimore) (2016) 0.78
Modification of the tear function index and its use in the diagnosis of Sjögren's syndrome. Br J Ophthalmol (2001) 0.76
The influence of religious fasting on basal tear secretion and tear break-up time. Int Ophthalmol (1999) 0.76
Sjögren's syndrome, bromhexine, and tear secretion. Br Med J (1978) 0.75
Agreement of noninvasive tear break-up time measurement between Tomey RT-7000 Auto Refractor-Keratometer and Oculus Keratograph 5M. Clin Ophthalmol (2016) 0.75
THE BLOOD FLOW, VASCULAR RESISTANCE, AND OXYGEN CONSUMPTION OF THE BRAIN IN ESSENTIAL HYPERTENSION. J Clin Invest (1948) 3.95
Atypical Pneumocystis carinii pneumonia in homosexual men with unusual immunodeficiency. AJR Am J Roentgenol (1982) 1.39
Visual fields in diabetic retinopathy. Br J Ophthalmol (1971) 1.15
Clinical experience with nucleosides in herpes simplex eye infections in man and animals. Ann N Y Acad Sci (1965) 1.09
Histocompatibility (HL-A) antigens and primary open-angle glaucoma. Tissue Antigens (1976) 1.05
Intraocular penetration of cephaloridine in humans. Am J Ophthalmol (1968) 1.05
Serratia marcescens, an ocular pathogen; new considerations. Arch Ophthalmol (1971) 1.04
The incidence of uveitis in multiple sclerosis. Am J Ophthalmol (1966) 1.04
Marginal (ring) corneal ulcer as presenting manifestation of Wegener's granuloma. A clinicopathologic study. Trans Am Acad Ophthalmol Otolaryngol (1971) 1.01
The role of lymphocyte (cell-mediated) immunity in ocular disease. The fifth Frederick H. Verhoeff lecture. Am J Ophthalmol (1973) 1.01
Ocular pigmentation and pressure and outflow responses to pilocarpine and epinephrine. Am J Ophthalmol (1971) 1.00
A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure. Am J Ophthalmol (1982) 0.96
The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol (1988) 0.95
Inhibition of leucocyte migration by corneal antigen in chronic viral keratitis. Nat New Biol (1971) 0.92
Oral isosorbide and intraocular pressure. Am J Ophthalmol (1970) 0.92
Clinical evaluation of the Humphrey automatic refractor. Arch Ophthalmol (1984) 0.91
Topical hetrazan in the treatment of ocular onchocerciasis. Am J Ophthalmol (1970) 0.90
Intraocular penetration of cephalexin in man. Am J Ophthalmol (1970) 0.90
Use of flurbiprofen to inhibit corneal neovascularization. Arch Ophthalmol (1980) 0.90
Cellular immunity in chronic ophthalmic disorders. 3. Leukocyte migration inhibition in uveitis. Am J Ophthalmol (1972) 0.89
New dimensions in ocular pharmacology. XXII Edward Jackson Memorial Lecture. Am J Ophthalmol (1966) 0.88
Clinical immunology in ophthalmology. The 1975 Bedell lecture. Am J Ophthalmol (1976) 0.88
Zinc deficiency and visual impairment? Am J Ophthalmol (1978) 0.87
The use of aceclydine in the treatment of glaucoma. Its effect on intraocular pressure and facility of aqueous humor outflow as compared to that of pilocarpine. Am J Ophthalmol (1967) 0.87
Mycobacterium fortuitum infection of corneal graft. Arch Ophthalmol (1969) 0.86
Treatment of uveitis with methotrexate. Am J Ophthalmol (1969) 0.86
Topical diethylcarbamazine in the treatment of ocular onchocerciasis. Am J Trop Med Hyg (1970) 0.85
Cellular immunity in chronic ophthalmic disorders. 2. Leukocyte migration inhibition in diseases of the cornea. Am J Ophthalmol (1972) 0.84
Leucocyte-migration inhibition induced by uveoretinal antigen in patients with diabetic retinopathy. Diabetes (1976) 0.83
Ocular penetration of hetrazan in rabbits. Am J Ophthalmol (1968) 0.83
Intraocular penetration of sodium cephalothin in man after subconjunctival injection. Am J Ophthalmol (1972) 0.83
Intraocular penetration of carbenicillin after subconjunctival injection in man. Am J Ophthalmol (1972) 0.83
Effect of hyperbaric oxygenation on microcirculation: use in therapy of retinal vascular disorders. Invest Ophthalmol (1965) 0.83
Trends in ocular therapy. Am J Ophthalmol (1968) 0.82
The phenylephrine saga--a drug dilemma. Am J Ophthalmol (1978) 0.82
Angiotensin-converting enzyme activity in ocular fluids. Invest Ophthalmol Vis Sci (1981) 0.81
Human cellular immunity to lens leukocyte migration inhibition by lens protein. Arch Intern Med (1974) 0.81
Editorial: The importance of HL-A antigens in ophthalmology. Am J Ophthalmol (1975) 0.81
Herellea vaginicola and ocular infections. Ann Ophthalmol (1975) 0.81
Leukocyte migration inhibition in chronic ophthalmic disorders. 5. Diabetic retinopathy and the effect of photocoagulation. Am J Ophthalmol (1973) 0.81
Noncorticosteroidal anti-inflammatory agents in Ophthalmology. Ophthalmology (1979) 0.81
Plasma zinc levels in multiple sclerosis. Metab Pediatr Ophthalmol (1980) 0.80
Four common ocular complications of diabetes--and how to treat them. Geriatrics (1978) 0.80
Intraocular penetrating of amoxicillin. Am J Ophthalmol (1976) 0.80
Management of intra-ocular infection. Trans Ophthalmol Soc U K (1971) 0.80
Antiproteolytic activities found in human tears. Ophthalmology (1981) 0.80
Resistance of rabbits and guinea pigs to the diabetogenic effect of streptozotocin. Diabetes (1969) 0.80
Intestinal absorption of dietary fat in patients with multiple sclerosis. Metab Pediatr Syst Ophthalmol (1985) (1993) 0.79
Excretion of salicylic acid into tears following oral administration of aspirin. Ophthalmology (1980) 0.79
Calcium in tears and contact lens wear. Arch Ophthalmol (1980) 0.79
Advances in ocular corticosteroid therapy. Med Clin North Am (1973) 0.79
Influence of topically applied prazosin on the intraocular pressure of experimental animals. Arch Ophthalmol (1979) 0.79
Advances in ocular therapy: noncorticosteroid anti-inflammatory agents. Fifth annual Jules Stein Lecture. Am J Ophthalmol (1974) 0.78
Prenatal diagnosis of cystic meconium peritonitis. J Clin Ultrasound (1984) 0.78
Forskolin, a potent adenylate cyclase activator, lowers rabbit intraocular pressure. Arch Ophthalmol (1984) 0.78
Topically applied oxymetazoline. Ocular vasoconstrictive activity, pharmacokinetics, and metabolism. Arch Ophthalmol (1983) 0.77
Intraocular penetration of cefazolin sodium in rabbits. Am J Ophthalmol (1974) 0.77
Studies on serum pseudocholinesterase in glaucoma. Am J Ophthalmol (1966) 0.77
Hereditary optic atrophy. An autosomal dominant with incomplete penetrance. Arch Ophthalmol (1969) 0.77
Advances in anesthesia in ophthalmic surgery. Ophthalmic Surg (1974) 0.77
Cholinesterase isoenzymes in rabbit ocular tissue homogenates. Doc Ophthalmol (1969) 0.77
The influence of systemic drugs on tear constituents. Ophthalmology (1979) 0.76
Cellular immunity in chronic ophthalmic disorders. I. Lymphocyte stimulation and protein synthesis. Am J Ophthalmol (1972) 0.76
Aqueous humor, cerebrospinal fluid, and atriopeptin. Am J Ophthalmol (1987) 0.76
The blood-aqueous and blood-brain barriers to permeability. Am J Ophthalmol (1988) 0.76
Studies on plasma cholinesterase isoenzymes in glaucoma. Am J Ophthalmol (1968) 0.76
Retinopathy in Rocky Mountain spotted fever. Am J Ophthalmol (1969) 0.76
Calcium and protein in tears: diurnal variation. Arch Ophthalmol (1981) 0.76
New antifungal therapy in ophthalmology. Trans Am Ophthalmol Soc (1973) 0.75
The multiple-choice question test of the American Board of Ophthalmology. Trans Am Ophthalmol Soc (1970) 0.75
The fifth Frederick H. Verhoeff Lecture. The role of the lymphocyte (cell-mediated) immunity in ocular disease. Trans Am Ophthalmol Soc (1973) 0.75
Ophthalmology-Epitomes of Progress: HLA Antigens and Glaucoma. West J Med (1979) 0.75
Leukocyte migration inhibition in chorioretinitis. Infect Immun (1974) 0.75
Hyperbaric oxygenation and corneal neovascularization in the rabbit. Am J Ophthalmol (1968) 0.75
Lens findings in patients with myasthenia gravis on long-term treatment with oral anticholinesterases. Mt Sinai J Med (1971) 0.75
Cataractogenic effect of ophthalmic preparations. Appl Ther (1970) 0.75
Steroids in ophthalmology. Bibl Ophthalmol (1967) 0.75
New dimensions in ocular pharmacology. Trans Am Acad Ophthalmol Otolaryngol (1967) 0.75
Lincomycin levels in rabbit ocular fluids and serum. Am J Ophthalmol (1971) 0.75
Cholinesterases and the effects and side-effects of drugs affecting cholinergic systems. Am J Ophthalmol (1966) 0.75
Lincomycin levels in human ocular fluids and serum following subconjunctival injection. Am J Ophthalmol (1971) 0.75
Ocular complications of drugs. Visual changes. JAMA (1968) 0.75
Intraocular penetration of methicillin. Am J Ophthalmol (1965) 0.75
Chemical injuries of the cornea. Fed Proc (1971) 0.75
The ophthalmologist and perinatal pharmacology. Arch Ophthalmol (1967) 0.75
Ocular examinations in outpatients given long-term chlorpromazine therapy. JAMA (1966) 0.75
Use of subconjunctival hyaluronidase. Am J Ophthalmol (1971) 0.75
Clinical pharmacologists in ophthalmology. Am J Ophthalmol (1972) 0.75
Diethylcarbamazine and uveitis. Isr J Med Sci (1970) 0.75
Cholinergic and anticholinesterase agents in glaucoma therapy. Trans Pac Coast Otoophthalmol Soc Annu Meet (1965) 0.75
Treatment of opportunistic infections of the eye. Mod Treat (1966) 0.75
Problems in ophthalmic drug therapy. Trans Am Acad Ophthalmol Otolaryngol (1972) 0.75
Intraocular penetration of rosoxacin in rabbits. Arch Ophthalmol (1982) 0.75
Glaucoma masque. Am J Ophthalmol (1967) 0.75
A symposium on glaucoma. Research, use of research findings, and physician-patient relationships for successful treatment. Sight Sav Rev (1966) 0.75
The steroid shield in ophthalmology. Trans Am Acad Ophthalmol Otolaryngol (1967) 0.75
Rabbit lens uptake of tritium-labelled phospholine iodide. Am J Ophthalmol (1969) 0.75
Topical anti-inflammatory steroids and intraocular pressure: the place of medrysone. Drugs (1971) 0.75
Cholinesterase isoenzymes in human ocular tissue homogenates. Am J Ophthalmol (1971) 0.75
The multiple-choice question test of the American Board of Ophthalmology. Am J Ophthalmol (1971) 0.75